SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 5th, 2018 • Apotheca Biosciences, Inc. • Metal mining • Nevada
This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of October 3, 2018, by and between APOTHECA BIOSCIENCES, INC., a Nevada corporation, with headquarters located at 10901 Roosevelt Blvd., Suite 1000c, Saint Petersburg, FL 33716 (the "Company"), and FIRSTFIRE GLOBAL OPPORTUNITIES FUND, LLC, a Delaware limited liability company, with its address at 1040 First Avenue, Suite 190, New York, NY 10022 (the "Buyer").
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 5th, 2018 • Apotheca Biosciences, Inc. • Metal mining • Nevada
REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of October 3, 2018, by and between APOTHECA BIOSCIENCES, INC., a Nevada corporation (the "Company"), and FIRSTFIRE GLOBAL OPPORTUNITIES FUND, LLC, a Delaware limited liability company (together with it permitted assigns, the "Buyer"). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the "Purchase Agreement").
COMMON STOCK PURCHASE WARRANT APOTHECA BIOSCIENCES, INC.Apotheca Biosciences, Inc. • November 5th, 2018 • Metal mining • Nevada
This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received (in connection with the issuance of the $300,000.00 senior convertible promissory note to the Holder (as defined below) of even date) (the "Note"), FirstFire Global Opportunities Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Apotheca Biosciences, Inc., a Nevada corporation (the "Company"), up to 480,000 shares of Common Stock (as defined below) (the "Warrant Shares") (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated October 3,
